Usui H - Search Results

1

Delayed postrenal failure due to progression of asymptomatic hydronephrosis following hysterectomy.

Haruishi M, Matsuoka A, Tate S, Arai T, Ichikawa T, Usui H. Haruishi M, et al. Among authors: usui h. J Obstet Gynaecol Res. 2023 Jun;49(6):1628-1632. doi: 10.1111/jog.15614. Epub 2023 Feb 15. J Obstet Gynaecol Res. 2023. PMID: 36792054

2

Concurrent daily cisplatin and extended-field radiation therapy for carcinoma of the cervix.

Uno T, Mitsuhashi A, Isobe K, Yamamoto S, Kawakami H, Ueno N, Usui H, Tate S, Kawata T, Ito H. Uno T, et al. Among authors: usui h. Int J Gynecol Cancer. 2008 Jan-Feb;18(1):80-4. doi: 10.1111/j.1525-1438.2007.00960.x. Epub 2007 Apr 26. Int J Gynecol Cancer. 2008. PMID: 17466053

3

Serum YKL-40 as a marker for cervical adenocarcinoma.

Mitsuhashi A, Matsui H, Usui H, Nagai Y, Tate S, Unno Y, Hirashiki K, Seki K, Shozu M. Mitsuhashi A, et al. Among authors: usui h. Ann Oncol. 2009 Jan;20(1):71-7. doi: 10.1093/annonc/mdn552. Epub 2008 Aug 22. Ann Oncol. 2009. PMID: 18723551 Free article.

4

The risk of post-molar gestational trophoblastic neoplasia is higher in heterozygous than in homozygous complete hydatidiform moles.

Baasanjav B, Usui H, Kihara M, Kaku H, Nakada E, Tate S, Mitsuhashi A, Matsui H, Shozu M. Baasanjav B, et al. Among authors: usui h. Hum Reprod. 2010 May;25(5):1183-91. doi: 10.1093/humrep/deq052. Epub 2010 Mar 5. Hum Reprod. 2010. PMID: 20208060

5

Postoperative concurrent daily low-dose cisplatin-based chemoradiation improves the prognosis of patients with pathologic T2b or N1 cervical cancer.

Mitsuhashi A, Uno T, Usui H, Tate S, Hirashiki K, Kato K, Kiyohara H, Kato S, Ito H, Shozu M. Mitsuhashi A, et al. Among authors: usui h. Anticancer Res. 2010 Jun;30(6):2341-6. Anticancer Res. 2010. PMID: 20651390

6

Comparison of 2 commercially available human chorionic gonadotropin immunoassays used in the management of gestational trophoblastic neoplasia.

Matsui H, Kihara M, Usui H, Tate S, Mitsuhashi A, Shozu M. Matsui H, et al. Among authors: usui h. J Reprod Med. 2009 Oct;54(10):631-5. J Reprod Med. 2009. PMID: 20677483

7

The application of a newly developed linear stapler preloaded with tissue reinforcement for distal pancreatectomy in the management of ovarian cancer.

Kato K, Tate S, Uehara T, Usui H, Mitsuhashi A, Shozu M. Kato K, et al. Among authors: usui h. Eur J Gynaecol Oncol. 2011;32(5):579-81. Eur J Gynaecol Oncol. 2011. PMID: 22053681

8

Daily low-dose cisplatin-based concurrent chemoradiotherapy in patients with uterine cervical cancer with emphasis on elderly patients: a phase 2 trial.

Mitsuhashi A, Uno T, Usui H, Nishikimi K, Yamamoto N, Watanabe M, Tate S, Hirashiki K, Kato K, Yamazawa K, Shozu M. Mitsuhashi A, et al. Among authors: usui h. Int J Gynecol Cancer. 2013 Oct;23(8):1453-8. doi: 10.1097/IGC.0b013e3182559bda. Int J Gynecol Cancer. 2013. PMID: 23266648 Clinical Trial.

9

Numerous psammoma bodies in cervical cytology of high-grade endocervical adenocarcinoma.

Uehara T, Kiyokawa T, Tate S, Usui H, Shozu M. Uehara T, et al. Among authors: usui h. Cytopathology. 2014 Aug;25(4):274-5. doi: 10.1111/cyt.12080. Epub 2013 Jul 15. Cytopathology. 2014. PMID: 23855933 No abstract available.

10

The Efficacy of Palonosetron Plus Dexamethasone in Preventing Chemoradiotherapy-induced Nausea and Emesis in Patients Receiving Daily Low-dose Cisplatin-based Concurrent Chemoradiotherapy for Uterine Cervical Cancer: A Phase II Study.

Mitsuhashi A, Usui H, Nishikimi K, Yamamoto N, Hanawa S, Tate S, Watanabe-Nemoto M, Uno T, Shozu M. Mitsuhashi A, et al. Among authors: usui h. Am J Clin Oncol. 2017 Apr;40(2):118-121. doi: 10.1097/COC.0000000000000117. Am J Clin Oncol. 2017. PMID: 25144265 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

472 results

Search Page